Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives

ES Ali, SM Sharker, MT Islam, IN Khan, S Shaw… - Seminars in cancer …, 2021 - Elsevier
Nanotechnology is reshaping health care strategies and is expected to exert a tremendous
impact in the coming years offering better healthcare facilities. It has led to not only …

Smart chemistry-based nanosized drug delivery systems for systemic applications: a comprehensive review

T Ramasamy, HB Ruttala, B Gupta, BK Poudel… - Journal of Controlled …, 2017 - Elsevier
This review focuses on the smart chemistry that has been utilized in developing polymer-
based drug delivery systems over the past 10 years. We provide a comprehensive overview …

Development of a graphene oxide nanocarrier for dual-drug chemo-phototherapy to overcome drug resistance in cancer

TH Tran, HT Nguyen, TT Pham, JY Choi… - … applied materials & …, 2015 - ACS Publications
Despite tremendous progress in chemotherapy, drug resistance remains a major challenge
for anticancer treatment. The combinations of chemo-photothermal and chemo-chemo …

Oral delivery of pH-responsive alginate microbeads incorporating folic acid-grafted solid lipid nanoparticles exhibits enhanced targeting effect against colorectal …

K Rajpoot, SK Jain - International journal of biological macromolecules, 2020 - Elsevier
To achieve an enhanced anticancer effect of drug to treat colorectal cancer, a dual-targeted
(ie, ligand-tailored and pH-triggered) multiparticulate system has been designed to deliver …

PEGylated lipid bilayer-supported mesoporous silica nanoparticle composite for synergistic co-delivery of axitinib and celastrol in multi-targeted cancer therapy

JY Choi, T Ramasamy, SY Kim, J Kim, SK Ku, YS Youn… - Acta biomaterialia, 2016 - Elsevier
Small-molecule drug combination therapies are an attractive approach to enhancing cancer
chemotherapeutic responses. Therefore, this study aimed to investigate the potential of …

Engineering of cell microenvironment-responsive polypeptide nanovehicle co-encapsulating a synergistic combination of small molecules for effective chemotherapy …

T Ramasamy, HB Ruttala, N Chitrapriya, BK Poudal… - Acta biomaterialia, 2017 - Elsevier
In this study, we report a facile method to construct a bioactive (poly (phenylalanine)-b-poly
(l-histidine)-b-poly (ethylene glycol) polypeptide nanoconstruct to co-load doxorubicin (DOX) …

Multimodal selenium nanoshell-capped Au@mSiO2 nanoplatform for NIR-responsive chemo-photothermal therapy against metastatic breast cancer

T Ramasamy, HB Ruttala, P Sundaramoorthy… - NPG Asia …, 2018 - nature.com
Multimodal therapeutic agents based on novel nanomaterials for multidrug resistance have
attracted increasing attention in cancer therapy. In this study, we describe the construction of …

Irinotecan-encapsulated double-reverse thermosensitive nanocarrier system for rectal administration

F Din, JY Choi, DW Kim, O Mustapha, DS Kim… - Drug Delivery, 2017 - Taylor & Francis
Intravenously administered for the treatment of rectum cancer, irinotecan produces severe
side effects due to very high plasma concentrations. A novel irinotecan-encapsulated double …

Paclitaxel and etoposide co-loaded polymeric nanoparticles for the effective combination therapy against human osteosarcoma

B Wang, XC Yu, SF Xu, M Xu - Journal of nanobiotechnology, 2015 - Springer
Background The combination of chemotherapeutic drugs with different pharmacological
action has emerged as a promising therapeutic strategy in the treatment of cancers. Present …

Advanced nanoscale drug delivery systems for bone cancer therapy

N Amiryaghoubi, M Fathi, J Barar, H Omidian… - … et Biophysica Acta (BBA …, 2023 - Elsevier
Bone tumors are relatively rare, which are complex cancers and primarily involve the long
bones and pelvis. Bone cancer is mainly categorized into osteosarcoma (OS) …